jakafi.com
This resource provides clear, medically focused information on Jakafi (ruxolitinib), detailing its approved us… 🔗
Global Rankeez rank — last updated 01 Oct 2026
Better than 97.3% of the 99,976,913 domains we track
Source breakdown
Rankeez combines several independent public rankings. Here's how jakafi.com scores in each:
| Source | Rank |
|---|---|
| Tranco (research-grade ranking, resistant to manipulation) | #3,529,477 |
| CommonCrawl (hyperlink graph) | #6,728,179 |
See how these sources are combined and cross-validated →
Ranking history
jakafi.com's rank across 3 monthly snapshots. ▲ improved by 10,330,846 since 2026-07
| Month | Rank |
|---|---|
| 2026-07 | #13,032,037 |
| 2026-08 | #4,889,317 |
| 2026-10 | #2,701,191 |
JSON API
{
"jakafi.com": 2701191,
"history": {
"2026-07": 13032037,
"2026-08": 4889317,
"2026-10": 2701191
}
}
GET https://rankeez.com/api/jakafi.com.json · see API docs →
More about jakafi.com
jakafi.com — page content & similar sites →
Learn about Jakafi® (ruxolitinib) – Used to treat adults with polycythemia vera who have taken hydroxyurea and it did not work well enough or they could not tolerate it, adults with certain types of myelofibrosis, and to treat adults and children 12 years
jakafi.com — full site profile →
WHOIS, tech stack and extended traffic history for jakafi.com.